atorvastatin calcium anhydrous has been researched along with rosuvastatin calcium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Sun, L; Zhou, W | 1 |
| Bode, C; Hidalgo, IJ; Li, J; Owen, A; Volpe, DA; Wang, Y; Zhang, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
3 other study(ies) available for atorvastatin calcium anhydrous and rosuvastatin calcium
| Article | Year |
|---|---|
Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.
Topics: Animals; Anticholesteremic Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hydroxymethylglutaryl CoA Reductases; Inhibitory Concentration 50; Molecular Structure; Phenols; Quinolines; Rats; Sulfhydryl Compounds | 2007 |
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
Topics: Blotting, Western; Caco-2 Cells; Carrier Proteins; Gene Expression; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; RNA, Small Interfering | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |